April 14 (UPI) --Pfizer on Monday announced it is halting ... patients are likely to suffer recurrences of cancerous tumors. Health News // 11 hours ago Crib mattresses can release toxic chemicals ...

Pfizer will stop developing an obesity pill that has been closely watched by investors, a severe blow in its efforts to compete with blockbuster weight-loss shots from Novo Nordisk A/S and Eli ...

Pfizer had intended to move the drug into late-stage testing, but called it quits after a patient in a clinical trial experienced a potentially drug-related liver injury. The drugmaker Pfizer is ...

Pfizer is halting development of its experimental weight-loss pill, as the booming obesity drug market remains out of reach for the drug giant. The company said Monday the stoppage comes after it ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and most expensive level of clinical testing. The drugmaker said Tuesday ...

In partnership with Ayala Healthcare Holdings Inc. (AC Health), the Inquirer management recently signed the “Working with Cancer” pledge to demonstrate the company’s commitment to support ...

After more than 13 years at Johnson & Johnson, including most recently serving as new ventures lead for Italy within J&J ...

The announcement sparked speculation that a number of health companies would be interested in buying the Pfizer business. These include GlaxoSmithKline, though it is already looking to buy ...

In 2017/2018 Pfizer attempted to sell its consumer health unit, but buyers including Proctor & Gamble and GSK pulled out of negotiations. This caused Pfizer to change its tactics, and instead the ...